TALEN

TALEN1-anos1b

ID

ZDB-TALEN-190412-2

Name

TALEN1-anos1b

Previous Names

None

Target

anos1b (1)

Target Sequence 1

5' - GCTCGGGGGTAAAGA - 3'

Target Sequence 2

5' - GGCAGGTGTGTCCGCATC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
sk52	anos1b
sk53	anos1b

Expression

Gene expression in Wild Types + TALEN1-anos1b

No data available

Phenotype

Phenotype resulting from TALEN1-anos1b

No data available

Phenotype of all Fish created by or utilizing TALEN1-anos1b

Phenotype	Fish	Conditions	Figures
posterior lateral line primordium anos1a expression absent, abnormal	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+	standard conditions	Fig. S3 from Wang et al., 2018
posterior lateral line neuromast decreased amount, abnormal	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+	standard conditions	Fig. 1 , Fig. 3 from Wang et al., 2018
posterior lateral line primordium anos1b expression absent, abnormal	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+	standard conditions	Fig. S3 from Wang et al., 2018
neuromast decreased size, abnormal	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+	standard conditions	Fig. 3 from Wang et al., 2018
posterior lateral line primordium GFP expression increased distribution, abnormal	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+; kyu2Tg; sk85Tg	standard conditions	Fig. 3 from Wang et al., 2018
neuromast decreased size, abnormal	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+; zf106Tg	standard conditions	Fig. 3 from Wang et al., 2018
posterior lateral line neuromast increased distance posterior lateral line neuromast, abnormal	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+; zf106Tg	standard conditions	Fig. 3 from Wang et al., 2018
posterior lateral line neuromast decreased amount, exacerbated	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+ + MO4-atoh1a	standard conditions	Fig. 1 from Wang et al., 2018
posterior lateral line neuromast decreased amount, abnormal	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+ + MO4-atoh1a	standard conditions	Fig. 1 from Wang et al., 2018
posterior lateral line neuromast decreased amount, abnormal	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+; sk89Tg	standard conditions	Fig. 3 from Wang et al., 2018
posterior lateral line neuromast increased distance posterior lateral line neuromast, ameliorated	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+; sk89Tg; zf106Tg	standard conditions	Fig. 3 from Wang et al., 2018
posterior lateral line neuromast decreased amount, abnormal	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+; zf106Tg + MO4-atoh1a	standard conditions	Fig. 1 from Wang et al., 2018
posterior lateral line neuromast decreased amount, abnormal	fgf3^{t24149/t24149}; anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+	standard conditions	Fig. 1 from Wang et al., 2018
posterior lateral line primordium EGFP expression decreased amount, abnormal	anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+; sk85Tg; sk89Tg + MO4-atoh1a	standard conditions	Fig. 4 from Wang et al., 2018
posterior lateral line neuromast decreased amount, abnormal	fgf3^{t24149/t24149}; anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+ + MO4-atoh1a	standard conditions	Fig. 1 from Wang et al., 2018
posterior lateral line neuromast decreased amount, abnormal	fgf3^{t24149/t24149}; anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+; zf106Tg + MO4-atoh1a	standard conditions	Fig. 1 from Wang et al., 2018
posterior lateral line neuromast primordium migration decreased efficacy, abnormal	fgf10a^tbvbo/+; fgf3^{t24149/t24149}; anos1a^sk50/+; anos1a^sk51/+; anos1b^sk52/+; anos1b^sk53/+; zf106Tg	standard conditions	Fig. 3 from Wang et al., 2018

Citations